Researchers are excited about Retatrutide , a groundbreaking dual agonist showing remarkable outcomes in initial trials for size loss . It works by targeting both hormones : GLP-1 and GIP, that , when https://kobiupoe084457.ampedpages.com/this-new-possibility-for-body-management-67785855